Company Profile

SHREE GANESH REMEDIES LTD.

NSE : NABSE : 540737ISIN CODE : INE414Y01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE239.050.8 (+0.34 % )
PREV CLOSE (Rs.) 238.25
OPEN PRICE (Rs.) 234.05
BID PRICE (QTY) 240.00 (204 )
OFFER PRICE (QTY) 241.85 (5 )
VOLUME 3200
TODAY'S LOW / HIGH (Rs.)234.05 249.95
52 WK LOW / HIGH (Rs.) 58.28 272.4
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 7.6496
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 16.47
ROCE (%) 32.63
Incorporation Year : 1995

Management Info :

- Chairman Chandulal Manubhai Kothia - Managing Director

Registered Office :

Address : Plot No. 6011,G I D C, ,
Ankleshwar,
Gujarat-393002

Phone : 02641 22777

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
18Feb02-18-2021$ Clarification sought from Shree Ganesh Remedies Ltd Clarification sought from S
The Exchange has sought clarification from Shree Ganesh Remedies Ltd on February 18, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.
The Exchange has sought clarification from Shree Ganesh Remedie..
18Jan01-18-2021$ Announcement under Regulation 30 (LODR)-Change in Directorate Announcement under Regulati
(a) Resignation of Mr. Hasmukhbhai Manubhai Kothia, (b) Induction of Mr. Parth Chandulal Kothia as an "Additional Director (Wholetime Director)" on the Board.
(a) Resignation of Mr. Hasmukhbhai Manubhai Kothia, (b) Induc..
06Jan01-06-2021$ Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter Ended On December 31, 2020. Board Meeting Intimation fo
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/01/2021 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on December 31, 2020.
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of t..
24Nov11-24-2020$Shree Ganesh Remedies gets nod for migrating Shares from SME platform to BSE Shree Ganesh Remedies gets n

Shree Ganesh Remedies has received approval from BSE for migrating the 10,006,446 Equity Shares of the Company from SME platform to Main Board platform of BSE with effective from November 25, 2020.

Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.

Shree Ganesh Remedies has received approval from BSE for migrat..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit27.7196.2399999999999
Gross Profit 34.79 127.44
Operating Profit 37.15151.26
Net Sales 132.64584.26
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 14679.00 (1.08%)
M.Cap ( in Cr)
30989.13
Piramal Enterprises (BSE)
 1987.00 (3.60%)
M.Cap ( in Cr)
44234.82
Gland Pharma (BSE)
 2416.95 (2.85%)
M.Cap ( in Cr)
39365.24
Procter&Gamble Healt (BSE)
 6827.45 (0.87%)
M.Cap ( in Cr)
11289.90
Orchid Pharma (BSE)
 1024.60 (5.00%)
M.Cap ( in Cr)
4182.05
Shareholding Pattern More
PROMOTERS 63.57 %
NON-INSTITUTION 36.43 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes